Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome
This study has been completed.
Study NCT00788073 Information provided by Seaside Therapeutics, Inc.
First Received on November 7, 2008. Last Updated on March 22, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fragile X Syndrome
More general conditions related to this trial
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Heredodegenerative Disorders, Nervous System
Mental Retardation, X-Linked
Nervous System Diseases
Sex Chromosome Disorders
Interventions listed in this trial
Sponsors listed in this trial
Seaside Therapeutics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers